These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 27417981)

  • 1. Changes in diabetes medications in the Diabetes and Periodontal Therapy Trial and their effect on hemoglobin A1c (HbA1c).
    Gelato MC; Schoenfeld E; Hou W; Michalowicz B; Seaquist E; Oates T; Tripathy D; Engebretson S; Hyman L
    Contemp Clin Trials; 2016 Sep; 50():21-7. PubMed ID: 27417981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design features of the Diabetes and Periodontal Therapy Trial (DPTT): a multicenter randomized single-masked clinical trial testing the effect of nonsurgical periodontal therapy on glycosylated hemoglobin (HbA1c) levels in subjects with type 2 diabetes and chronic periodontitis.
    ; Engebretson S; Gelato M; Hyman L; Michalowicz BS; Schoenfeld E
    Contemp Clin Trials; 2013 Nov; 36(2):515-26. PubMed ID: 24080100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial.
    Engebretson SP; Hyman LG; Michalowicz BS; Schoenfeld ER; Gelato MC; Hou W; Seaquist ER; Reddy MS; Lewis CE; Oates TW; Tripathy D; Katancik JA; Orlander PR; Paquette DW; Hanson NQ; Tsai MY
    JAMA; 2013 Dec; 310(23):2523-32. PubMed ID: 24346989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjustments to diabetes medications in response to increases in hemoglobin a1c: an epidemiologic study.
    Davis J; Chavez B; Juarez DT
    Ann Pharmacother; 2014 Jan; 48(1):41-7. PubMed ID: 24449495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and laboratory evaluations of non-surgical periodontal treatment in subjects with diabetes mellitus.
    da Cruz GA; de Toledo S; Sallum EA; Sallum AW; Ambrosano GM; de Cássia Orlandi Sardi J; da Cruz SE; Gonçalves RB
    J Periodontol; 2008 Jul; 79(7):1150-7. PubMed ID: 18597596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Inflammatory Biomarkers and Their Association With Periodontal and Diabetes-Related Factors in the Diabetes and Periodontal Therapy Trial, A Randomized Controlled Trial.
    Geisinger ML; Michalowicz BS; Hou W; Schoenfeld E; Gelato M; Engebretson SP; Reddy MS; Hyman L
    J Periodontol; 2016 Aug; 87(8):900-13. PubMed ID: 27108476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sub-antimicrobial doxycycline for periodontitis reduces hemoglobin A1c in subjects with type 2 diabetes: a pilot study.
    Engebretson SP; Hey-Hadavi J
    Pharmacol Res; 2011 Dec; 64(6):624-9. PubMed ID: 21782948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is insulin the most effective injectable antihyperglycaemic therapy?
    Buse JB; Peters A; Russell-Jones D; Furber S; Donsmark M; Han J; MacConell L; Maggs D; Diamant M
    Diabetes Obes Metab; 2015 Feb; 17(2):145-51. PubMed ID: 25323312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensification of medication and glycaemic control among patients with type 2 diabetes - the ADVANCE trial.
    van Dieren S; Kengne AP; Chalmers J; Beulens JW; Davis TM; Fulcher G; Heller SR; Patel A; Colagiuri S; Hamet P; Mancia G; Marre M; Neal B; Williams B; Peelen LM; van der Schouw YT; Woodward M; Zoungas S
    Diabetes Obes Metab; 2014 May; 16(5):426-32. PubMed ID: 24251579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.
    Simpson TC; Weldon JC; Worthington HV; Needleman I; Wild SH; Moles DR; Stevenson B; Furness S; Iheozor-Ejiofor Z
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD004714. PubMed ID: 26545069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in HbA1c following minimal or enhanced non-surgical, non-antibiotic treatment of gingivitis or mild periodontitis in type 2 diabetic patients: a pilot trial.
    Madden TE; Herriges B; Boyd LD; Laughlin G; Chiodo G; Rosenstein D
    J Contemp Dent Pract; 2008 Jul; 9(5):9-16. PubMed ID: 18633464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study.
    Jones JA; Miller DR; Wehler CJ; Rich SE; Krall-Kaye EA; McCoy LC; Christiansen CL; Rothendler JA; Garcia RI
    J Clin Periodontol; 2007 Jan; 34(1):46-52. PubMed ID: 17137468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initiation of prandial insulin therapy with AIR inhaled insulin or insulin lispro in patients with type 2 diabetes: A randomized noninferiority trial.
    Gross JL; Nakano M; Colon-Vega G; Ortiz-Carasquillo R; Ferguson JA; Althouse S; Tobian JA; Berclaz PY; Milicevic Z
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S27-34. PubMed ID: 19772446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Starting insulin therapy in patients with type 2 diabetes: effectiveness, complications, and resource utilization.
    Hayward RA; Manning WG; Kaplan SH; Wagner EH; Greenfield S
    JAMA; 1997 Nov; 278(20):1663-9. PubMed ID: 9388085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Long-Term Periodontal Care on Hemoglobin A1c in Type 2 Diabetes.
    Merchant AT; Georgantopoulos P; Howe CJ; Virani SS; Morales DA; Haddock KS
    J Dent Res; 2016 Apr; 95(4):408-15. PubMed ID: 26701348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial.
    Ludvik B; Giorgino F; Jódar E; Frias JP; Fernández Landó L; Brown K; Bray R; Rodríguez Á
    Lancet; 2021 Aug; 398(10300):583-598. PubMed ID: 34370970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial.
    Frias JP; Nauck MA; Van J; Kutner ME; Cui X; Benson C; Urva S; Gimeno RE; Milicevic Z; Robins D; Haupt A
    Lancet; 2018 Nov; 392(10160):2180-2193. PubMed ID: 30293770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial treatment with rosiglitazone/metformin fixed-dose combination therapy compared with monotherapy with either rosiglitazone or metformin in patients with uncontrolled type 2 diabetes.
    Rosenstock J; Rood J; Cobitz A; Biswas N; Chou H; Garber A
    Diabetes Obes Metab; 2006 Nov; 8(6):650-60. PubMed ID: 17026489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Subcutaneous Tirzepatide vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial.
    Dahl D; Onishi Y; Norwood P; Huh R; Bray R; Patel H; Rodríguez Á
    JAMA; 2022 Feb; 327(6):534-545. PubMed ID: 35133415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cardiovascular outcomes in a type 2 diabetes glucose supply and insulin demand model.
    Monte SV; Schentag JJ; Adelman MH; Paladino JA
    J Diabetes Sci Technol; 2010 Mar; 4(2):382-90. PubMed ID: 20307400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.